Committed to Patient Safety Screening and Eating Disorder Risk GLP-1s are not appropriate for every individual with a substance use disorder, and careful screening is essential
We commonly use BPC-157 as part of our treatment for the following conditions: Chronic gastrointestinal (GI) issues, including colitis, Crohns disease, irritable bowel disease (IBD), gastritis, ulcers, and esophagitis
Restore normal sight to those inflicted with blurred vision
For example, the fact that insulin levels go down may have to do not only with Metformins effect on glucose, but because autophagy has increased, mitochondrial function is better, genetic stability is good, etc
Some providers may prescribe phentermine for a few weeks to kickstart weight loss while a patient is slowly titrating up to their full dose of a GLP-1